hesperidin has been researched along with paclitaxel in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Brito, DA; Kenny, AE; Rieder, CL; Yang, Z | 1 |
| Floreani, M; Moro, S; Palatini, P; Quintieri, L | 1 |
| Arikan, SM; Dogan, T; Kandemir, FM; Kaynar, O; Semis, HS | 1 |
| Caglayan, C; Gur, C; Kandemir, FM; Satıcı, E | 1 |
| Akaras, N; Genc, A; Ileriturk, M; Kandemir, FM; Kandemir, O; Simsek, H | 1 |
8 other study(ies) available for hesperidin and paclitaxel
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Cells satisfy the mitotic checkpoint in Taxol, and do so faster in concentrations that stabilize syntelic attachments.
Topics: Animals; Aurora Kinase B; Aurora Kinases; Calcium-Binding Proteins; Cell Cycle Proteins; Cell Line; Cyclin B; Dose-Response Relationship, Drug; Focal Adhesion Kinase 1; Hesperidin; Humans; Kinetochores; Mad2 Proteins; Microtubules; Mitosis; Nocodazole; Paclitaxel; Protein Serine-Threonine Kinases; Recombinant Fusion Proteins; Repressor Proteins; Spindle Apparatus; Tubulin Modulators | 2009 |
Inhibition of cytochrome P450 2C8-mediated drug metabolism by the flavonoid diosmetin.
Topics: Aryl Hydrocarbon Hydroxylases; Binding Sites; Cytochrome P-450 CYP2C8; Flavonoids; Hesperidin; Humans; Inactivation, Metabolic; Microsomes, Liver; Molecular Dynamics Simulation; Paclitaxel | 2011 |
The protective effects of hesperidin against paclitaxel-induced peripheral neuropathy in rats.
Topics: Animals; Antineoplastic Agents, Phytogenic; Dose-Response Relationship, Drug; Hesperidin; Male; Neuroprotective Agents; Paclitaxel; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley | 2021 |
Chemopreventive effects of hesperidin against paclitaxel-induced hepatotoxicity and nephrotoxicity via amendment of Nrf2/HO-1 and caspase-3/Bax/Bcl-2 signaling pathways.
Topics: Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Chemical and Drug Induced Liver Injury; Hesperidin; NF-E2-Related Factor 2; Oxidative Stress; Paclitaxel; Rats; Signal Transduction | 2022 |
Hesperidin has a protective effect on paclitaxel-induced testicular toxicity through regulating oxidative stress, apoptosis, inflammation and endoplasmic reticulum stress.
Topics: Animals; Antioxidants; Apoptosis; Endoplasmic Reticulum Stress; Endoribonucleases; Hesperidin; Inflammation; Oxidative Stress; Paclitaxel; Protein Serine-Threonine Kinases; Rats | 2023 |